WST stock: buy or sell?
February 21st, 2020
West Pharmaceutical Services, Inc. manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally.
Should I buy WST stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to choose your own trading plan that fits your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, 2 buy setups are elegible for West Pharmaceutical Services stock right now:
|New all-time high||Yes|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is West Pharmaceutical Services stock a buy?
Banks and financial institutions post stock ratings everyday.Unfortunately, we couldn't find any rating for WST stock for the last month.
WST stock analysis
West Pharmaceutical Services declined -0.88% to $170.16 after reaching all time highs on Wednesday.
After marking all time highs on Wednesday, West Pharmaceutical Services declined -0.88% to $170.16. From a daily perspective, WST is in a short term uptrend after plotting its last bottom ($158.43, on Feb 7th) higher than the previous bottom, and its last top ($176.66, on Wednesday) also over the previous top. Now trading in between its last bottom and last top WST might consolidate in a plain range, waiting to break out over $176.66 or down under $158.43. On Wednesday, WST hit new all time highs, pushing higher previous ATH of $175.21 recorded on Feb/14. New ATHs are usual entry points for many trading setups as there aren't higher resistences. Since last October when WST stock price broke up the SMA50d line, it gained $27.81 (19.54%).
After boosting an amazing 8.87% in a week last week, West Pharmaceutical Services closed this week at $170.16 and fell an awful -2.53%.
Price pattern shows an uptrend with two rising tops and bottoms, and now finally trading above the $151.00 resistance. WST hit new all-time highs again this week, setting highs to $176.66. Since SMA20d and SMA40w crossed up late May 2019, WST price climbed $54.26 per share (46.82%). Since price and SMA40w lines crossed up late March 2019, WST climbed $66.97 (64.90%).
WST stock price history
WST IPO was on March 17th, 1980 at $0.00 per share1. Since then, WST stock grew a inf%, with a yearly average of inf%. If you had invested $1,000 in WST stock in 1980, it would worth $inf today.
1: Adjusted price after possible price splits or reverse-splits.
WST stock historical price chart
WST stock reached all-time highs on Wednesday with a price of $176.66.
WST stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not detected any price forecast for West Pharmaceutical Services stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share, West Pharmaceutical Services reported its latest financial data, in line with analysts' consensus and posted a $0.73 Earnings per Share. Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual turnover report draw a great growth of 7.40% to $1,717.40 M dollars. When comparing 2018 vs 2017, likewise, profit margin (that is, the net income divided by revenues) grew a 2.62% to 12.05%.
|2013||$1,370 M||-||$112 M8.2%||-|
|2014||$1,421 M||3.75%||$127 M8.9%||13.18%|
|2015||$1,400 M||-1.52%||$96 M6.8%||-24.78%|
|2016||$1,509 M||7.81%||$144 M9.5%||50.21%|
|2017||$1,599 M||5.96%||$151 M9.4%||4.94%|
|2018||$1,717 M||7.40%||$207 M12.0%||37.29%|
Quarterly financial resultsWest Pharmaceutical Services posted $422.50 M in revenues for 2018-Q4, a -2.13% decline compared to previous quarter. Reported quarter earnings marked $52.00 million with a profit margin of 12.31%. Profit margin stayed stable a -0.48% compared to previous quarter when profit margin was 12.79%. When comparing sales to same quarter last year, West Pharmaceutical Services sales marked a slightly fine gain and raised a 1.66%. Looking back to recent quarterly results, West Pharmaceutical Services posted 2 negative quarters in a row.
|2017-Q2||$398 M||-||$39 M9.8%||-|
|2017-Q3||$399 M||0.23%||$51 M12.8%||31.44%|
|2017-Q4||$416 M||4.24%||$0 M0.0%||-100.00%|
|2018-Q1||$416 M||0.02%||$44 M10.5%||0.00%|
|2018-Q2||$448 M||7.65%||$56 M12.5%||28.67%|
|2018-Q3||$432 M||-3.53%||$55 M12.8%||-1.60%|
|2018-Q4||$423 M||-2.13%||$52 M12.3%||-5.80%|
|2019-Q1||$444 M||4.97%||$55 M12.5%||6.54%|
West Pharmaceutical Services ownershipWhen you are planning to buy shares of a stock, it's worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For West Pharmaceutical Services, 0.96% of all outstanding shares are owned by its staff.
Bearish positions for WST stock account 0.00%, no big difference from last month.
For a better understanding, the following table shows ownership data compared to other related stocks:
|Market cap||$12.6 B|
|Total shares||74.0 M|
|Float shares||73.3 M|
|- Institutional holdings (%)||94.2%|
|- Insider holdings (%)||1.0%|
|Shares in short selling||0.0%|
|Friday, February 21st, 2020|
|Day range||$169.76 - $171.72|
|Average true range||$3.45|
|50d mov avg||$156.19|
|100d mov avg||$150.25|
|200d mov avg||$140.33|
West Pharmaceutical Services performanceTo measure stock performance is always good to compare with competitors or related stocks. We compared West Pharmaceutical Services against in the following table: